Georgia vs Netherlands: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Georgia
80.0%
in 2025
Netherlands
81.0%
in 2025
Georgia rank
108th
Netherlands rank
106th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Georgia
- Netherlands
How they compare
Netherlands currently reports 81.0% against 80.0% in Georgia, a difference of 1.0%.
The two have swapped places 6 times across 26 shared years of data; in 2000 it was Netherlands ahead.
Georgia ranks 108th and Netherlands ranks 106th of 194 countries.
Netherlands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Georgia | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 60.5% | 75.5% | 15.0% | Netherlands |
| 2010s | 87.5% | 91.5% | 4.0% | Netherlands |
| 2020s | 80.5% | 84.5% | 4.0% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Georgia or Netherlands?
- Netherlands, at 81.0% against 80.0% in Georgia as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Georgia and Netherlands?
- 1.0%, with Netherlands ahead.
- How many years of comparable data are there for Georgia and Netherlands?
- 26 years are reported by both, from 2000 to 2025.
- How do Georgia and Netherlands rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Georgia ranks 108th and Netherlands ranks 106th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.